Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older

Gerbrand J. Izaks*, Aafke M. van der Knaap, Ron T. Gansevoort, Gerjan Navis, Joris P. J. Slaets, Robin P. F. Dullaart

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

Common polymorphisms of the Cholestryl Ester Transfer Protein (CETP) gene may predict lower risk of cognitive decline. We investigated the association of cognitive function with CETP genotype in a population-based cohort of 4135 persons aged 35-82 years. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0 points; best score, 175 points) and CETP I405V and Taq1B genotypes were determined by polymerase chain reaction. RFFT score was not associated with I405V genotype in persons aged 35-64 years. Remarkably, beyond age 65, homozygous valine carriers had higher RFFT scores than heterozygous carriers and noncarriers: RFFT (SD), 52 (21), 49 (18), and 47 (17) points, respectively (p = 0.005). There also was a statistically significant interaction between I405V genotype and age. Beyond age 65, the difference between homozygous valine carriers and noncarriers increased by 0.11 point per year (p = 0.005). RFFT score was not associated with Taq1B genotype. In conclusion, CETP I405V valine homozygosity was associated with better cognitive function in persons aged 65 years or older. (C) 2012 Elsevier Inc. All rights reserved.

Original languageEnglish
Article numberARTN 1851.e7
Number of pages10
JournalNeurobiology of Aging
Volume33
Issue number8
DOIs
Publication statusPublished - Aug-2012

Keywords

  • CETP
  • Cross-sectional analysis
  • Executive function
  • Genetic association study
  • Middle-aged
  • Systematic review
  • DENSITY-LIPOPROTEIN CHOLESTEROL
  • ALZHEIMERS-DISEASE RISK
  • GENETIC ASSOCIATION
  • POLYMORPHISM
  • BRAIN
  • DEMENTIA
  • DECLINE
  • MIDLIFE
  • INDIVIDUALS
  • OBESITY

Cite this